생명과학회지 (Journal of Life Science)

  • 제28권12호
  • /
  • Pages.1507-1515
  • /
  • 2018
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

Sprague Dawley 흰쥐에서 테스토스테론에 의하여 유발된 전립선 비대증에 미치는 산수유 추출물의 영향

Effects of Corni Fructus on Testosterone-induced Benign Prostatic Hyperplasia in Sprague Dawley Rats

  • 권다혜 (동의대학교 항노화연구소) ;
  • 황보현 (동의대학교 항노화연구소) ;
  • 최은옥 (동의대학교 항노화연구소) ;
  • 김민영 (동의대학교 항노화연구소) ;
  • 지선영 (동의대학교 항노화연구소) ;
  • 김경일 (구례산수유영농조합법인) ;
  • 박노진 (구례산수유영농조합법인) ;
  • 김성옥 (경성대학교 식품응용공학부) ;
  • 홍수현 (동의대학교 항노화연구소) ;
  • 박철 (동의대학교 분자생물학과) ;
  • 황혜진 (동의대학교 식품영양학과) ;
  • 정지숙 (구례산수유영농조합법인) ;
  • 최영현 (동의대학교 항노화연구소)
  • Kwon, Da He (Anti-Aging Research Center, Dongeui University) ;
  • Hwangbo, Hyun (Anti-Aging Research Center, Dongeui University) ;
  • Choi, Eun Ok (Anti-Aging Research Center, Dongeui University) ;
  • Kim, Min Yeong (Anti-Aging Research Center, Dongeui University) ;
  • Ji, Seon Yeong (Anti-Aging Research Center, Dongeui University) ;
  • Kim, Kyung-Il (Gurye Sansooyu Farming Association Corporation) ;
  • Park, No-Jin (Gurye Sansooyu Farming Association Corporation) ;
  • Kim, Sung Ok (Department of Food Science and Biotechnology, College of Engineering, Kyungsung University) ;
  • Hong, Su-Hyun (Anti-Aging Research Center, Dongeui University) ;
  • Park, Cheo (Department of Molecular Biology, College of Natural Sciences, Dongeui University) ;
  • Hwang, Hye-Jin (Department of Food and Nutrition, College of Nursing, Healthcare Sciences & Human Ecology, Dongeui University) ;
  • Jeong, Ji-Suk (Gurye Sansooyu Farming Association Corporation) ;
  • Choi, Yung Hyun (Anti-Aging Research Center, Dongeui University)
  • 투고 : 2018.06.27
  • 심사 : 2018.08.05
  • 발행 : 2018.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

노년기 비뇨기 계통에 가장 흔한 증상의 하나인 전립선 비대증은 요도를 둘러싼 전립선의 주위의 평활근과 상피세포의 과다 증식에 의한 것이다. 산수유는 강력한 항산화 효과로 인하여 다양한 질병의 예방 및 치료에 효과적이라고 보고되었지만 전립선 비대증에 대한 효능은 아직 알려지지 않았다. 본 연구에서는 산수유 열수 추출물이 testosterone에 의하여 유도되는 전립선 비대증에 미치는 영향을 조사하였다. 실험동물 내재성 testosterone의 영향을 배제하기 위해 거세를 하였으며, 전립선 비대증을 유도하기 위해, testosterone propionate (TP)를 피하 주사하였다. 산수유 추출물은 TP 주입과 함께 매일 경구 투여하였고, $5{\alpha}$-reductase type 2의 선택적 억제제인 finasteride를 양성 대조군으로 사용하였다. 본 연구의 결과에 의하면, 산수유 추출물 투여군에서는 finasteride 처리군에서와 마찬가지로 혈청 내 dihydrotestosterone 농도가 억제되었으며 전립선 무게 증가와 조직병리학적 변화가 유의하게 감소되었다. 산수유 추출물은 또한 전립선 조직 및 혈청에서 각각 TP에 의해 증가된 $5{\alpha}$-reductase type 2의 발현 및 농도를 유의적으로 억제하였다. 아울러 산수유 추출물은 TP에 의하여 유도된 AR, AR의 co-activator 및 세포증식 마커 단백질들의 발현 증가뿐 만 아니라 prostate-specific antigen의 수치와 발현도 감소시켰다. 결론적으로 산수유 추출물은 전립선 비대억제를 위한 식의약 소재로서의 개발 가능성이 매우 높음을 의미한다.

Benign prostatic hyperplasia (BPH) is characterized by prostatic hypertrophy mainly in the elderly. Corni Fructus is reportedly effective in the prevention and treatment of various diseases, but its efficacy on BPH has not been previously studied. In the present study, we investigated whether or not a Corni Fructus water extract (CF) could prevent testosterone-induced prostatic hyperplasia in rats. To induce BPH, castrated rats were subcutaneously injected with testosterone propionate (TP). CF was administered daily by oral gavage, along with the TP injections, and finasteride, a selective inhibitor of $5{\alpha}$-reductase type 2, was used as a positive control. The results show that CF significantly reduces prostate weight and histopathologic changes while also decreasing levels of serum dihydrotestosterone, similar to the finasteride-treated group. CF also suppresses TP-induced $5{\alpha}$-reductase expression and concentration in prostate tissue and serum, respectively. Furthermore, CF markedly inhibited TP-induced expression of the androgen receptor (AR) and the steroid receptor coactivator 1, an AR coactivator, which was associated with a decrease in prostate-specific antigen levels in both serum and prostate tissue. In conclusion, the results of this study indicate that CF weakens BPH status by inactivation of $5{\alpha}$-reductase and AR.

키워드

SMGHBM_2018_v28n12_1507_f0001.png 이미지

Fig. 1. Effects of CF administration on prostate weights in TP-induced BPH rats.

SMGHBM_2018_v28n12_1507_f0002.png 이미지

Fig. 2. Effects of CF administration on the histological changes in the prostate tissues and DHT in serum of TP-induced BPH rats.

SMGHBM_2018_v28n12_1507_f0003.png 이미지

Fig. 3. Effects of CF administration on 5α-reductase type 2 in TP-induced BPH rats.

SMGHBM_2018_v28n12_1507_f0004.png 이미지

Fig. 4. Effects of CF administration on the expression of AR, SRC1, PCNA and cyclins in TP-induced BPH rats.

SMGHBM_2018_v28n12_1507_f0005.png 이미지

Fig. 5. Effects of CF administration on PSA in TP-induced BPH rats.

Table 1. Classification of experiment groups

SMGHBM_2018_v28n12_1507_t0001.png 이미지

Table 2. Effects of CF treatment on the several organ weights of TP-induced BHP rats

SMGHBM_2018_v28n12_1507_t0002.png 이미지

Table 3. Effects of CF treatment on the serum biochemical parameters for the liver and kidney functions of TP-induced BHP rats

SMGHBM_2018_v28n12_1507_t0003.png 이미지

참고문헌

  1. Aaron, L., Franco, O. E. and Hayward, S. W. 2016. Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia. Urol. Clin. North. Am. 43, 279-288. https://doi.org/10.1016/j.ucl.2016.04.012
  2. Al-Khalil, S., Boothe, D., Durdin, T., Sunkara, S., Watkins, P., Yang, S., Haynes, A. and de Riese, W. 2016. Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review. Int. Urol. Nephrol. 48, 91-97. https://doi.org/10.1007/s11255-015-1146-2
  3. Andriole, G., Bruchovsky, N., Chung, L. W., Matsumoto, A. M., Rittmaster, R., Roehrborn, C., Russell, D. and Tindall, D. 2004. Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J. Urol. 172, 1399-1403. https://doi.org/10.1097/01.ju.0000139539.94828.29
  4. Azzouni, F. and Mohler, J. 2012. Role of 5${\alpha}$-reductase inhibitors in benign prostatic diseases. Prostate Cancer Prostatic Dis. 15, 222-230. https://doi.org/10.1038/pcan.2012.1
  5. Boehm, E. M., Gildenberg, M. S. and Washington, M. T. 2016. The many roles of PCNA in eukaryotic DNA replication. Enzymes 39, 231-254.
  6. Bostanci, Y., Kazzazi, A., Momtahen, S., Laze, J. and Djavan, B. 2013. Correlation between benign prostatic hyperplasia and inflammation. Curr. Opin. Urol. 23, 5-10. https://doi.org/10.1097/MOU.0b013e32835abd4a
  7. Botticelli, A. R., Criscuolo, M., Martinelli, A. M., Botticelli, L., Filoni, A. and Migaldi, M. 1993. Proliferating cell nuclear antigen/cyclin in incidental carcinoma of the prostate. Virchows Arch. A Pathol. Anat. Histopathol. 423, 365-368.
  8. Chang, J. S., Chiang, L. C., Hsu, F. F. and Lin, C. C. 2004. Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro. Am. J. Chin. Med. 32, 717-725. https://doi.org/10.1142/S0192415X04002296
  9. Choe, K. N. and Moldovan, G. L. 2017. Forging ahead through darkness: PCNA, still the principal conductor at the replication Fork. Mol. Cell 65, 380-392. https://doi.org/10.1016/j.molcel.2016.12.020
  10. Cornu, J. N., Ahyai, S., Bachmann, A., de la Rosette, J., Gilling, P., Gratzke, C., McVary, K., Novara, G., Woo, H. and Madersbacher, S. 2015. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: An update. Eur. Urol. 67, 1066-1096. https://doi.org/10.1016/j.eururo.2014.06.017
  11. Gharaee-Kermani, M. and Macoska, J. A. 2013. Promising molecular targets and biomarkers for male BPH and LUTS. Curr. Urol. Rep. 14, 628-637. https://doi.org/10.1007/s11934-013-0368-z
  12. Ho, C. K. and Habib, F. K. 2011. Estrogen and androgen signaling in the pathogenesis of BPH. Nat. Rev. Urol. 8, 29-41. https://doi.org/10.1038/nrurol.2010.207
  13. Huang, J., Zhang, Y., Dong, L., Gao, Q., Yin, L., Quan, H., Chen, R., Fu, X. and Lin, D. 2018. Ethnopharmacology, phytochemistry, and pharmacology of Cornus officinalis Sieb. et Zucc. J. Ethnopharmacol. 213, 280-301. https://doi.org/10.1016/j.jep.2017.11.010
  14. Hwang, K. A., Hwang, Y. J. and Song, J. 2016. Antioxidant activities and oxidative stress inhibitory effects of ethanol extracts from Cornus officinalis on raw 264.7 cells. BMC Complement. Altern. Med. 16, 196. https://doi.org/10.1186/s12906-016-1172-3
  15. Jeong, E. J., Kim, T. B., Yang, H., Kang, S. Y., Kim, S. Y., Sung, S. H. and Kim, Y. C. 2012. Neuroprotective iridoid glycosides from Cornus officinalis fruits against glutamateinduced toxicity in HT22 hippocampal cells. Phytomedicine 19, 317-321. https://doi.org/10.1016/j.phymed.2011.08.068
  16. Jiang, W. L., Chen, X. G., Zhu, H. B., Hou, J. and Tian, J. W. 2009. Cornuside attenuates apoptosis and ameliorates mitochondrial energy metabolism in rat cortical neurons. Pharmacology 84, 162-170. https://doi.org/10.1159/000235621
  17. Kang, D. G., Moon, M. K., Lee, A. S., Kwon, T. O., Kim, J. S. and Lee, H. S. 2007. Cornuside suppresses cytokine-induced proinflammatory and adhesion molecules in the human umbilical vein endothelial cells. Biol. Pharm. Bull. 30, 1796-1799. https://doi.org/10.1248/bpb.30.1796
  18. Keam, S. J. and Scott, L. J. 2008. Dutasteride: a review of its use in the management of prostate disorders. Drugs 68, 463-485. https://doi.org/10.2165/00003495-200868040-00008
  19. Lepor, H. 2016. Alpha-blockers for the treatment of benign prostatic hyperplasia. Urol. Clin. North. Am. 43, 311-323. https://doi.org/10.1016/j.ucl.2016.04.009
  20. Ma, W., Wang, K. J., Cheng, C. S., Yan, G. Q., Lu, W. L., Ge, J. F., Cheng, Y. X. and Li, N. 2014. Bioactive compounds from Cornus officinalis fruits and their effects on diabetic nephropathy. J. Ethnopharmacol. 153, 840-845. https://doi.org/10.1016/j.jep.2014.03.051
  21. Minciullo, P. L., Inferrera, A., Navarra, M., Calapai, G., Magno, C. and Gangemi, S. 2015. Oxidative stress in benign prostatic hyperplasia: a systematic review. Urol. Int. 94, 249-254. https://doi.org/10.1159/000366210
  22. Nakayama, Y. and Yamaguchi, N. 2013. Role of cyclin B1 levels in DNA damage and DNA damage-induced senescence. Int. Rev. Cell. Mol. Biol. 305, 303-337.
  23. Nemoto, R., Kawamura, H., Miyakawa, I., Uchida, K., Hattori, K., Koiso, K. and Harada, M. 1993. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA)/cyclin in human prostate adenocarcinoma. J. Urol. 149, 165-169. https://doi.org/10.1016/S0022-5347(17)36031-7
  24. Nicholson, T. M. and Ricke, W. A. 2011. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. Differentiation 82, 184-199. https://doi.org/10.1016/j.diff.2011.04.006
  25. Park, J. Y., Han, A. R., Kil, Y. S., Kang, U., Kim, S. H., Nam, S. J. and Seo, E. K. 2016. A new secoiridoid glycoside from the fruits of Cornus officinalis (Cornaceae). Nat. Prod. Res. 30, 1504-1510. https://doi.org/10.1080/14786419.2015.1115996
  26. Pihlajamaa, P., Sahu, B. and Janne, O. A. 2015. Determinants of receptor- and tissue-specific actions in androgen signaling. Endocr. Rev. 36, 357-384. https://doi.org/10.1210/er.2015-1034
  27. Pomerantz, Y. and Dekel, N. 2013. Molecular participants in regulation of the meiotic cell cycle in mammalian oocytes. Reprod. Fertil. Dev. 25, 484-494. https://doi.org/10.1071/RD12242
  28. Prins, G. S. 2000. Molecular biology of the androgen receptor. Mayo Clin. Proc. 75, S32-35.
  29. Pyo, J. S. and Cho, W. J. 2017. Systematic review and metaanalysis of prostatic artery embolisation for lower urinary tract symptoms related to benign prostatic hyperplasia. Clin. Radiol. 72, 16-22. https://doi.org/10.1016/j.crad.2016.10.009
  30. Robins, D. M. 2005. Androgen receptor and molecular mechanisms of male-specific gene expression. Novartis Found. Symp. 268, 42-52.
  31. Romero Otero, J., Garcia Gomez, B., Campos Juanatey, F. and Touijer, K. A. 2014. Prostate cancer biomarkers: an update. Urol. Oncol. 32, 252-260. https://doi.org/10.1016/j.urolonc.2013.09.017
  32. Seo, J. Y., Pyo, E., Park, J., Kim, J. S., Sung, S. H. and Oh, W. K. 2017. Nrf2-mediated HO-1 induction and antineuroinflammatory activities of halleridone. J. Med. Food 20, 1091-1099. https://doi.org/10.1089/jmf.2017.3949
  33. Smith, R. D. and Patel, A. 2011. Transurethral resection of the prostate revisited and updated. Curr. Opin. Urol. 21, 36-41. https://doi.org/10.1097/MOU.0b013e3283411455
  34. Steers, W. D. 2001. 5alpha-reductase activity in the prostate. Urology 58, S17-24. https://doi.org/10.1016/S0090-4295(01)01299-7
  35. Strand, D. W., Costa, D. N., Francis, F., Ricke, W. A. and Roehrborn, C. G. 2017. Targeting phenotypic heterogeneity in benign prostatic hyperplasia. Differentiation 96, 49-61. https://doi.org/10.1016/j.diff.2017.07.005
  36. Telang, N. T., Li, G., Sepkovic, D. W., Bradlow, H. L. and Wong, G. Y. 2012. Anti-proliferative effects of Chinese herb Cornus officinalis in a cell culture model for estrogen receptor-positive clinical breast cancer. Mol. Med. Rep. 5, 22-28.
  37. Thorner, D. A. and Weiss, J. P. 2009. Benign prostatic hyperplasia: symptoms, symptom scores, and outcome measures. Urol. Clin. North. Am. 36, 417-429. https://doi.org/10.1016/j.ucl.2009.07.001
  38. Traish, A. M., Melcangi, R. C., Bortolato, M., Garcia-Segura, L. M. and Zitzmann, M. 2015. Adverse effects of 5${\alpha}$-reductase inhibitors: What do we know, don't know, and need to know? Rev. Endocr. Metab. Disord. 16, 177-198. https://doi.org/10.1007/s11154-015-9319-y
  39. Traish, A. M. 2012. $5{\alpha}$-reductases in human physiology: an unfolding story. Endocr. Pract. 18, 965-975. https://doi.org/10.4158/EP12108.RA
  40. Van Coppenolle, F., Le Bourhis, X., Carpentier, F., Delaby, G., Cousse, H., Raynaud, J. P., Dupouy, J. P. and Prevarskaya, N. 2000. Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon) on rat prostate hyperplasia induced by hyperprolactinemia: comparison with finasteride. Prostate 43, 49-58. https://doi.org/10.1002/(SICI)1097-0045(20000401)43:1<49::AID-PROS7>3.0.CO;2-J
  41. Vignozzi, L., Rastrelli, G., Corona, G., Gacci, M., Forti, G. and Maggi, M. 2014. Benign prostatic hyperplasia: a new metabolic disease? J. Endocrinol. Invest. 37, 313-322. https://doi.org/10.1007/s40618-014-0051-3
  42. Yoon, J. H., Youn, K., Ho, C. T., Karwe, M. V., Jeong, W. S. and Jun, M. 2014. p-Coumaric acid and ursolic acid from Corni fructus attenuated ${\beta}$-amyloid(25-35)-induced toxicity through regulation of the NF-${\kappa}B$ signaling pathway in PC12 cells. J. Agric. Food Chem. 62, 4911-4916. https://doi.org/10.1021/jf501314g